{"id":42842,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/strain-access-agreement-maxygen-inc-and-agraquest-inc.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"strain-access-agreement-maxygen-inc-and-agraquest-inc","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/operations\/strain-access-agreement-maxygen-inc-and-agraquest-inc.html","title":{"rendered":"Strain Access Agreement &#8211; Maxygen Inc. and AgraQuest Inc."},"content":{"rendered":"<pre>                            STRAIN ACCESS AGREEMENT\n\n     This Strain Access Agreement (the \"Agreement\"), effective as of December\n21, 2000 (the \"Effective Date\"), is made by and between Maxygen, Inc., a\nDelaware corporation (\"Maxygen\"), and AgraQuest, Inc., a Delaware corporation\n(\"AgraQuest\"). Maxygen shall mean Maxygen and its Affiliates.\n\n                                  BACKGROUND\n\nA.   AgraQuest has an extensive collection of organisms in its biodiversity\n     collection (\"Collection\") and is willing to provide access to Maxygen, on a\n     non-exclusive basis to at least three thousand (3,000) strains of organisms\n     in the Collection.\n\nB.   Maxygen wishes to obtain samples of strains in the Collection in order to\n     utilize the strains and material derived from the strains for its benefit.\n\n     Now Therefore, for and in consideration of the covenants, conditions and\nundertakings set forth, it is agreed by and between the parties as follows:\n\n1.   DEFINITIONS\n\n     1.1  \"Affiliate\" means any corporation, firm, limited liability company,\npartnership or other entity that directly or indirectly controls or is\ncontrolled by or is under common control with another person.\n\n     1.2  \"Biopesticide\" means a product intended for use as a Pesticide that\n(i) contains a microorganism as the active component or (ii) consists of an\nextract from a microorganism as the active component that contains a naturally\noccurring substance that controls pests by non-toxic mechanisms.  For the\npurposes of this definition, \"Biopesticide\" shall not include any pesticidal\nsubstance that a plant or plant cells produce from genetic material that has\nbeen introduced into the plant or plant cells (nor shall it include such plant\nor plant cells).\n\n     1.3  \"Collection Strain\" means a strain of organism found in the\nCollection.\n\n     1.4  \"Confidential Information\" means any (i) proprietary or confidential\ninformation or material in tangible form disclosed by one party to the other\nhereunder that is marked as \"Confidential\" at the time it is delivered to the\nreceiving party, or (ii) proprietary or confidential information disclosed\norally hereunder that is identified as confidential or proprietary when\ndisclosed and confirmed in writing as confidential within [***] days after such\noral disclosure.\n\n     1.5  \"Derived Material\" means any material, genetic or otherwise, obtained\nfrom any Selected Strain and any derivatives or modifications made by or for\nMaxygen or any of its sublicensees from any Selected Strain or material obtained\ntherefrom.\n\n     1.6  \"Liability\" means any liabilities, damages, settlements, claims,\npenalties, fines, and reasonable costs or reasonable expenses (including,\nwithout limitation, reasonable attorneys' fees and other expenses of\nlitigation).\n\n     1.7  \"Pesticide\" is as defined in the Federal Insecticide, Fungicide and\nRodenticide Act (Section 136(u) of Title 7, Chapter 6 of the United States\nCode).\n\n     1.8  \"Selected Strain\" means a Collection Strain selected by Maxygen to be\nreceived from AgraQuest pursuant to this Agreement.\n\n                                       1\n\n[***] Confidential information has been omitted and filed separately with the \nSecurities and Exchange Commission pursuant to 17 C.F.R. Section 230.406.\n\n\n\n\n\n\n \n     1.9  \"Shuffling\" means the recombination and\/or rearrangement and\/or\nmutation of genetic material for the creation of genetic diversity using\nintellectual property and\/or tangible property owned or controlled by Maxygen.\n\n     1.10 \"Strain Information\" means all information on a Collection Strain,\nincluding, without limitation, taxonomic information, information regarding\nbiological and\/or biochemical activities and any information concerning\nintellectual property rights relating to the strain, including rights owned or\ncontrolled by AgraQuest and any rights of third parties.  Strain Information\nwill include, without limitation, information sufficient for Maxygen to be able\nto identify strains of interest for its various research projects.  Strain\nInformation will also include, without limitation, information identifying the\nsource of the strain, including the country of original collection and the date\nof collection.\n\n2.   ACCESS TO STRAINS\n\n     2.1  Samples.\n\n          2.1.1     Sample Size. Maxygen will have the right to select which\nCollection Strains it is to receive from AgraQuest. AgraQuest will supply\nMaxygen with samples of at least three thousand (3,000) different Collection\nStrains.\n\n          2.1.2     Timing\/Rate of Delivery. AgraQuest will deliver to Maxygen\nthe Selected Strains within thirty (30) days after delivery of notice to\nAgraQuest of which Collection Strains Maxygen chooses to receive. It is\nanticipated that concurrently with the execution of this Agreement, Maxygen will\nnotify AgraQuest of (i) up to [***] Collection Strains Maxygen chooses to\nreceive within thirty (30) days of the Effective Date and (ii) an additional\n[***] Collection Strains Maxygen chooses to receive within sixty (60) days of\nthe Effective Date. Thereafter, Maxygen will notify AgraQuest of an additional\n[***] to [***] Collection Strains per month that Maxygen chooses to receive.\n\n          2.1.3     Preparation of Samples. Each Selected Strain provided to\nMaxygen by AgraQuest pursuant to this Agreement will be provided as follows:\nEach Selected Strain will be delivered as glycerol stocks in 2 ml vials. The\nvials will be delivered frozen. Shipments of samples of Selected Strains will be\nprovided in sample boxes shipped in dry ice. Shipments shall be packaged so as\nto arrive at Maxygen with the samples still frozen. [***].\n\n     2.2  Information\n\n          2.2.1     Delivery of Information. Prior to the Effective Date, or as\nsoon as practicable thereafter, AgraQuest will provide to Maxygen all Strain\nInformation within its possession or control concerning each Collection Strain\ncurrently in the Collection.\n\n          2.2.2     Future Information. AgraQuest will provide Maxygen with\nStrain Information concerning any future strain isolated by AgraQuest, or\notherwise added to the Collection, until Maxygen has selected three thousand\n(3,000) strains of organisms from the Collection. Strain Information on newly\nisolated strains shall be provided to Maxygen as soon as practicable after being\nobtained.\n\n     2.3  Exploitation. Subject to Section 4.3, Maxygen will have the right to\nexploit each of the Selected Strains and\/or Derived Material in any manner that\nMaxygen deems appropriate.\n\n3.   OWNERSHIP AND RIGHTS IN THE SELECTED STRAINS.\n\n                                       2\n\n[***] Confidential information has been omitted and filed separately with the \nSecurities and Exchange Commission pursuant to 17 C.F.R. Section 230.406.\n\n\n \n     3.1  Independent Development. AgraQuest retains the right to continue\nindependent development and investigation of any Selected Strain for which it\nmay provide a sample to Maxygen. [***].\n\n     3.2  Maxygen Ownership.  Subject to Section 4.3, by virtue of Maxygen's\nreceipt of a Selected Strain under this Agreement:\n\n          3.2.1     Derived Material.  [***].\n\n          3.2.2     Intellectual Property. Maxygen shall own all rights to and\ninterest in any idea, invention (whether patentable or not), discovery or\nimprovement made by or for Maxygen and\/or its sublicensees and related to the\nSelected Strains or Derived Material, and any uses of the Selected Strains or\nDerived Material obtained through use of the Selected Strains or Derived\nMaterial by or for Maxygen and\/or its sublicensees, and Maxygen and\/or its\nsublicensees shall be free to use any such idea, invention, discovery or\nimprovement, without further obligation to AgraQuest.\n\n4.   LICENSES.\n\n     4.1  License to Selected Strains. AgraQuest hereby grants Maxygen a \nnon-exclusive, worldwide [***] license, [***] to propagate and use the Selected\nStrains [***]. Maxygen sublicensees will be bound by the terms of the license\ngranted to Maxygen in this Section 4.1.\n\n     4.2  License to Intellectual Property. AgraQuest hereby grants Maxygen a\nnon-exclusive, worldwide [***] license [***]. Maxygen sublicensees will be bound\nby the terms of the license granted to Maxygen in this Section 4.2.\n\n     4.3  AgraQuest Retained Rights. It is understood and agreed that the\nlicenses granted to Maxygen and any of its sublicensees in Sections 4.1 and 4.2\nshall not include the right of Maxygen or its sublicensees to use any Selected\nStrain (with or without modification) as a Biopesticide. AgraQuest also retains\n(i) the right to use the Selected Strains for any purpose and (ii) its\nintellectual property rights relating to the Selected Strains.\n\n     4.4  No License of Maxygen Property. No rights or licenses with respect to\nany intellectual property owned by Maxygen or its Affiliates are granted or will\nbe deemed granted to AgraQuest under this Agreement.\n\n5.   PAYMENTS TO AGRAQUEST\n\n     5.1  Collection Access Fee. Maxygen will pay to AgraQuest a one-time\nCollection access fee of [***] within ten (10) business days of the Effective\nDate.\n\n     5.2  Milestones.\n\n          5.2.1     Commercial Development. Maxygen will pay to AgraQuest a\nmilestone payment of [***] upon the commencement of commercial development by\nMaxygen or any of its sublicensees of each of its products that contain a gene\nisolated from a Selected Strain; provided, however, that milestone payments\npursuant to this Section 5.2.1 shall [***].  The commencement of commercial\ndevelopment shall occur upon (i) for agricultural products, production of \nT2 transgenic seeds of the applicable product or (ii) for chemical products,\nproduction in a 200-liter fermenter of the applicable product.\n\n          5.2.2     Commercial Sale. Maxygen will pay to AgraQuest a milestone\npayment of [***] upon the first commercial sale by Maxygen or any of its\nsublicensees of each of its products that contain a gene isolated from a\nSelected Strain; provided, however, that milestone payments pursuant to this\nSection 5.2.2 shall [***].\n\n          5.2.3     Gene Isolated from a Collection Strain. For the purposes of\nthis Section 5.2, a \"gene isolated from a Collection Strain\" means an unmodified\ngene isolated from a Selected Strain (or a fragment thereof) or a modified form\nof a gene isolated from a Selected Strain (or a fragment thereof); provided,\nhowever, in each case that such gene or fragment thereof provides or allows an\nactivity that cannot be obtained without such gene or fragment.\n\n     5.3  Reports and Payments\n\n                                       3\n\n\n[***] Confidential information has been omitted and filed separately with the \nSecurities and Exchange Commission pursuant to 17 C.F.R. Section 230.406.\n\n \n          5.3.1     Milestone Reports. Maxygen will provide AgraQuest with\nreports of the attainment of each milestone described in Section 5.2.1 and\nSection 5.2.2 as soon as practicable after such event and in any case within\nsixty (60) days of such event.\n\n          5.3.2     Milestone Payment. Concurrently with making the reports\ndescribed in Section 5.3.1, Maxygen will pay the amounts due under Section 5.2.1\nand Section 5.2.2.\n\n6.   FUTURE NEGOTIATIONS\n\n     If Maxygen elects, on or before the third anniversary of the Effective\nDate, to commercialize a protein product (e.g., an enzyme) expressed from a gene\nisolated from a Selected Strain as a Biopesticide, then Maxygen will give\nwritten notice to AgraQuest of its intention; provided, however, that Maxygen\nshall have no obligation to breach any duty of confidentiality to a third party.\nIn such event, AgraQuest and Maxygen will negotiate in good faith for a period\nof up to ninety (90) days from the date of Maxygen's notice, or such further\nperiod as the parties may agree in writing, to enter into a written agreement\nestablishing the terms of such commercialization by AgraQuest. If no written\nagreement is executed within such time Maxygen will have no further obligation\nto AgraQuest with respect thereto.\n\n7.   REPRESENTATIONS\n\n     7.1  Sole Owner. AgraQuest represents and warrants that it is the (i) sole\nand exclusive owner of, or (ii) co-owner and exclusive licensee of, each of the\nSelected Strains and has the right to provide the Selected Strains and the\nStrain Information to Maxygen along with any other rights described herein,\nwithout violating its obligations to third parties.\n\n     7.2  No Payment Obligations. AgraQuest represents and warrants that there\nare no, and will not be any, payment or other obligations to third parties that\nwould result from the use by Maxygen or its sublicensees of any Selected Strains\nor Derived Material.\n\n     7.3  Power and Authority. Each party represents and warrants that it has\nthe legal power, authority and right to enter into this Agreement and to perform\nits respective obligations set forth herein.\n\n     7.4  No Conflict. Each party represents and warrants that as of the\nEffective Date of this Agreement it is not a party to any agreement or\narrangement with any third party or under any obligation or restriction,\nincluding pursuant to its certificate of incorporation or bylaws, that in any\nway limits or conflicts with its ability to fulfill any of its obligations under\nthis Agreement, and will not enter into any such agreement during the term of\nthis Agreement.\n\n     7.5  Power to Grant Rights. Each party represents and warrants that it has\nthe right to grant the other party hereto the rights provided under this\nAgreement.\n\n8.   CONFIDENTIALITY.\n\n     8.1  Confidential Information. Except as expressly provided herein, the\nparties agree that, for the term of this Agreement and for five (5) years \nthereafter, the receiving party shall keep completely confidential and shall not\npublish or otherwise disclose and shall not use for any purpose except for the\npurposes contemplated by this Agreement any Confidential Information furnished\nto it by the disclosing party hereto, except that to the extent that it can be\nestablished by the receiving party by written proof that such Confidential\nInformation:\n\n          (a)  was already known to the receiving party, other than under an\n     obligation of confidentiality, at the time of disclosure;\n\n          (b)  was generally available to the public or otherwise part of the\n     public domain at the time of its disclosure to the receiving party;\n\n                                       4\n\n[***] Confidential information has been omitted and filed separately with the \nSecurities and Exchange Commission pursuant to 17 C.F.R. Section 230.406.\n\n \n          (c)  became generally available to the public or otherwise part of the\n     public domain after its disclosure and other than through any act or\n     omission of the receiving party in breach of this Agreement;\n\n          (d)  was subsequently lawfully disclosed to the receiving party by a\n     person other than a party hereto; or\n\n          (e)  was independently developed by the receiving party without use of\n     or reference to Confidential Information.\n\n     8.2  Permitted Use and Disclosures. Each party may disclose Confidential\nInformation disclosed to it by the other party:\n\n          (a)  to the extent such use or disclosure is reasonably necessary in\n     complying with applicable law or regulation or legal process, provided that\n     if a party is required to make any such disclosure of the other party's\n     Confidential Information, other than pursuant to a confidentiality\n     agreement, it will give reasonable advance notice to the latter party of\n     such disclosure and, will use reasonable efforts to secure confidential\n     treatment of such information prior to its disclosure; or\n\n          (b)  is necessary in (x) filing or prosecuting patent applications,\n     (y) prosecuting or defending litigation, or (z) making a permitted\n     sublicense or otherwise exercising license rights expressly granted by the\n     other party to it under this Agreement.\n\n     8.3  Public Disclosures. Either party may disclose that an Agreement exists\nbetween them; however, neither party can disclose the terms of this Agreement\nwithout written consent from the other party.\n\n     8.4  Confidential Terms. Notwithstanding Section 8.3, disclosures may be\nmade to the extent required to advisors so long as the advisors are bound by\nconfidentiality obligations comparable to the parties hereto.\n\n9.   INDEMNITY.\n\n     9.1  Maxygen Indemnity to AgraQuest. Maxygen shall indemnify, defend and\nhold harmless AgraQuest from and against any claims, actions or suits by a third\nparty resulting in any Liability arising out of or resulting from (i) a breach\nof any representation of Maxygen in Section 7 or (ii) Maxygen's use of any\nSelected Strain or Derived Material or the development or manufacture, use,\npromotion, marketing, sale or other distribution of any product by Maxygen or\nits sublicensees including any Selected Strain or Derived Material, except to\nthe extent such Liability resulted from AgraQuest's negligence or wrongdoing.\n\n     9.2  AgraQuest Indemnity to Maxygen. AgraQuest shall indemnify, defend and\nhold harmless Maxygen from and against any claims, actions or suits by a third\nparty resulting in any Liability arising out of or resulting from (i) a breach\nof any representation of AgraQuest in Section 7 or (ii) Maxygen's use of any\nSelected Strain or Derived Material or the development or manufacture, use,\npromotion, marketing, sale or other distribution of any product by Maxygen or\nits sublicensees including any Selected Strain or Derived Material to the extent\nsuch Liability resulted from AgraQuest's negligence or wrongdoing.\n\n10.  TERMINATION.\n\n     10.1 Term. This Agreement shall be effective as of the Effective Date and,\nunless otherwise terminated earlier pursuant to the terms of this Section 10,\nshall continue in full force and effect until the [***] of the Effective Date.\n\n     10.2 Termination for Cause. Either party may terminate this Agreement in\nthe event the other party has materially breached or defaulted in the\nperformance of any of its obligations hereunder, and such default has continued\nfor sixty (60) days after written notice thereof was provided to the breaching\nparty by the nonbreaching party.\n\n                                       5\n\n[***] Confidential information has been omitted and filed separately with the \nSecurities and Exchange Commission pursuant to 17 C.F.R. Section 230.406.\n\n \nAny termination shall become effective at the end of such sixty (60) day period\nunless the breaching party has cured any such breach or default prior to the\nexpiration of such period.\n\n     10.3 Effect of Termination.\n\n          10.3.1    Accrued Rights and Obligations. Termination of this\nAgreement for any reason shall not release any party hereto from any liability\nthat, at the time of such termination, has already accrued to the other party or\nthat is attributable to a period prior to such termination, nor preclude either\nparty from pursuing any rights and remedies it may have hereunder or at law or\nin equity with respect to any breach of this Agreement.\n\n          10.3.2    Material Breach by Maxygen. If AgraQuest terminates this\nAgreement pursuant to Section 10.2, the licenses granted to Maxygen in Sections\n4.1 and 4.2 shall terminate and the provisions of Sections 4.3 and 5 shall\nsurvive; provided, however, that if the material breach or default causing the\ntermination relates only to certain Selected Strains and\/or certain products,\nthe licenses granted to Maxygen in Sections 4.1 and 4.2 shall terminate only in\nregard to such Selected Strains and\/or products and shall survive as to all\nother Selected Strains and products.\n\n          10.3.3    Material Breach by AgraQuest. If Maxygen terminates this\nAgreement pursuant to Section 10.2: (i) AgraQuest shall pay to Maxygen an access\ntermination fee equal to [***] pursuant to Section 2.1.1 and (ii) the provisions\nof Sections 4, 5 and 6 shall not survive.\n\n          10.3.4    Other Termination. If this Agreement terminates according to\nSection 10.1, the provisions of Sections 2.3, 4 and 5 shall survive the\ntermination of this Agreement.\n\n          10.3.5    Survival. The provisions of Sections 3, 4.4, 7, 8, 9, 10 and\n11 shall survive the expiration or termination of this Agreement for any reason.\n\n11.  MISCELLANEOUS.\n\n     11.1 Governing Law; Venue. This Agreement and any dispute arising from the\nperformance or breach hereof shall be governed by and construed and enforced in\naccordance with the laws of the state of California, without reference to\nconflicts of laws principles. The exclusive venue of any dispute arising out of\nor in connection with the performance or breach of this Agreement shall be the\nCalifornia state courts in or U.S. district court for the County of San Mateo,\nCA, and the parties hereby consent to the personal jurisdiction of such courts.\n\n     11.2 Assignment; Successors. This Agreement shall not be assignable by\neither party to any third party without the written consent of the other party;\nexcept either party may assign this Agreement, without such consent, to (i) an\nAffiliate of such party; or (ii) an entity that acquires all or substantially\nall of the business or assets of such party, whether by merger, reorganization,\nacquisition, sale, or otherwise, which agrees in writing to be bound by the\nterms and conditions of this Agreement. The terms and conditions of this\nAgreement shall be binding on and inure to the benefit of the permitted\nsuccessors and assigns of the parties.\n\n     11.3 Notices. Any notices, requests and other communications hereunder\nshall be in writing and shall be personally delivered or sent by international\nexpress delivery service, registered or certified mail, return receipt\nrequested, postage prepaid, in each case to the respective address specified\nbelow, or such other address as may be specified in writing to the other party\nhereto:\n\n          Maxygen:       Maxygen, Inc.\n                         515 Galveston Drive\n                         Redwood City, CA 94063\n                         Attn: General Counsel\n\n          AgraQuest:     AgraQuest, Inc.\n\n                                       6\n\n\n[***] Confidential information has been omitted and filed separately with the \nSecurities and Exchange Commission pursuant to 17 C.F.R. Section 230.406.\n\n \n                         1530 Drew Avenue\n                         Davis, CA 95616\n                         Attn: President\n\n     11.4 Independent Contractors. The relationship of the parties is that of\nindependent contractors. The parties are not deemed to be agents, partners or\njoint venturers of the other for any purpose as a result of this Agreement or\nthe transactions contemplated hereby.\n\n     11.5 Further Assurances. Each party shall execute and cause to be delivered\nto the other party such instruments and other documents, and shall take such\nother actions, as such other party may reasonably request in order for the\nrequesting party to obtain the full benefits of this Agreement and the\ntransactions contemplated hereby.\n\n     11.6 Compliance with Laws. In exercising their rights under this license,\nthe parties shall fully comply in all material respects with the requirements of\nany and all applicable laws, regulations, rules and orders of any governmental\nbody having jurisdiction over the exercise of rights under this Agreement.\n\n     11.7 Entire Agreement; Amendment. This Agreement constitutes the entire\nagreement, both written and oral, with respect to the subject matter hereof, and\nsupersedes all prior or contemporaneous understandings or agreements, whether\nwritten or oral, with respect to such subject matter. This Agreement may only be\namended in a writing signed by both parties.\n\n     11.8 Headings. The captions to the Sections are not a part of this\nAgreement, but are included merely for convenience of reference and shall not\naffect its meaning or interpretation.\n\n     11.9 Counterparts. This Agreement may be executed in two counterparts, each\nof which shall be deemed an original and which together shall constitute one\ninstrument.\n\n     In Witness Whereof, the parties have executed and delivered this Agreement\nas of the date first above written.\n\nMaxygen, Inc.                           AgraQuest, Inc.\n\nBy:\/s\/ John R. Bedbrook                   By: \/s\/ Pamela G. Marrone\n   --------------------                       ----------------------\n   Name:John R. Bedbrook                      Name: Pamela G. Marrone\n   Title: President of Agriculture            Title: President &amp; CEO\n\n                                       7\n\n[***] Confidential information has been omitted and filed separately with the \nSecurities and Exchange Commission pursuant to 17 C.F.R. Section 230.406.\n\n<\/pre>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[6597,8151],"corporate_contracts_industries":[9451],"corporate_contracts_types":[9613,9616],"class_list":["post-42842","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-agraquest-inc","corporate_contracts_companies-maxygen-inc","corporate_contracts_industries-manufacturing__chemicals","corporate_contracts_types-operations","corporate_contracts_types-operations__ip"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/42842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=42842"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=42842"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=42842"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=42842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}